Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-2,568
Closed -$139K 170
2015
Q2
$139K Hold
2,568
0.01% 125
2015
Q1
$141K Hold
2,568
0.01% 126
2014
Q4
$139K Hold
2,568
0.01% 115
2014
Q3
$145K Hold
2,568
0.01% 106
2014
Q2
$142K Buy
2,568
+53
+2% +$2.89K 0.01% 112
2014
Q1
$136K Hold
2,515
0.01% 111
2013
Q4
$120K Buy
2,515
+105
+4% +$4.8K 0.01% 110
2013
Q3
$110K Hold
2,410
0.01% 99
2013
Q2
$107K Buy
+2,410
New +$108K 0.01% 94

Other funds holding MRK

Friess Associates's MRK Position: Q3 2015 in Review

Friess Associates sold out of Merck (MRK) in Q3 2015, closing a stake of 2,568 shares — an estimated $139K sold.

Friess Associates first reported a position in MRK in Q2 2013 and held it in 9 quarters. The position peaked at $145K in Q3 2014. 1,672 funds tracked by Wall St. Rank hold MRK as of Q3 2015.

  • Friess Associates reported no remaining Merck position as of Q3 2015 after selling out during the quarter.
  • Friess Associates sold 2,568 Merck shares in Q3 2015, an estimated $139K.
  • Friess Associates first reported a position in Merck in Q2 2013 and held it in 9 quarters.
  • Friess Associates's Merck position peaked at $145K in Q3 2014.
  • 1,672 funds tracked by Wall St. Rank held Merck as of Q3 2015.

Based on Friess Associates's 13F filing for Q3 2015, filed 13 Nov 2015.